— Know what they know.
Not Investment Advice
Asset Manager ← All Institutions

Remedium Capital Partners, LLC

Q1 2026 · Filed 2026-05-19
Market Value
$232M
Holdings
5
New Purchases
0
Added To
2
Closed
0
Reduced
0
Top 10 Concentration
100.0%
Turnover
0.0%

Sector Allocation Over Time

Market Cap Concentration

TierHoldingsValueWeight
Mid Cap 2 $150M 64.8%
Small Cap 3 $82M 35.2%

Portfolio Analytics

Avg Market Cap
$2.0B
Median Market Cap
$1.5B
Avg P/E
Median P/E
Avg Dividend Yield
—%
Avg Beta
1.50
# Stocks
5
# ETFs / Funds
0

Top Holdings (5 total)

# Symbol % Port Shares Value Avg Price Q/Q Value Chg Share Chg Chg % Status
1 ORKA 33.10% 1,565,661 $77M $49.05 $30M +13,247 +0.8%
2 SYRE 31.66% 1,456,231 $73M $50.44 $26M
3 DMRA 22.83% 2,045,473 $53M $25.90 $50M +1,925,000 +1597.9%
4 JBIO 9.55% 1,577,750 $22M $14.05 -$2M
5 GLYC 2.86% 361,250 $7M $18.37 $2M
View SEC EDGAR Filings for Remedium Capital Partners, LLC →

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms